首页|HSP90抑制剂的设计、合成及与氟康唑联合使用抗耐药真菌活性评价

HSP90抑制剂的设计、合成及与氟康唑联合使用抗耐药真菌活性评价

扫码查看
目的 设计并合成一系列2-[(反式-4-羟基环己基)氨基]苯甲酰胺类HSP90抑制剂,测试其与氟康唑联合使用对耐药真菌的抑制活性.方法 以2-溴-4-氟苯腈为起始原料,经亲核取代、Buchwald-Hartwig偶联和氰基水解得到化合物A1~A7;以2-氟-4-(溴甲基)苯腈为起始原料,经亲电取代、亲核取代和氰基水解得到化合物A8和A9;以2-巯基苯并咪唑及其衍生物为起始原料,经Ullmann偶联、亲核取代、Buchwald-Hartwig偶联和氰基水解得到化合物A10~A16.采用二倍稀释法,以氟康唑与化合物SNX-2112联合使用为阳性对照,氟康唑单独使用为阴性对照,测定目标化合物对6种氟康唑耐药真菌(Strain 901、Strain 904、Strain 632、Strain 100、Strain 103和Strain311)的抑制活性.结果 与结论合成了 16个2-[(反式-4-羟基环己基)氨基]苯甲酰胺类化合物,其结构均经核磁共振氢谱和质谱确证,体外抑菌活性测试结果表明,大多数目标化合物对测试耐药真菌均表现出不同程度的抑制作用,其中与氟康唑联合使用时目标化合物A11的抑菌活性略优于先导化合物SNX-2112.本研究对氟康唑与HSP90抑制剂联合使用的抗耐药真菌活性进行了初步探索,为后续更深入的研究提供了有价值的参考.
Design,synthesis and evaluation of HSP90 inhibitors combined with fluconazole against azole-resistant candidiasis
Using SNX-2112 as the lead compound,sixteen 2-[(trans-4-hydroxycyclohexyl)amino]benzamide HSP90 inhibitors were designed and synthesized.The target compounds A1-A7 were synthesized from 2-bromo-4-fluorobenzonitrile by nucleophilic substitution,Buchwald-Hartwig coupling and nitrile hydrolysis.The target compounds A8 and A9 were obtained from 4-(bromomethyl)-2-fluorobenzonitrile by electrophilic substitution,nucleophilic substitution and nitrile hydrolysis.The target compounds A10-A16 were obtained from 2-mercaptobenzimidazole and its derivatives by Ullmann coupling,nucleophilic substitution,Buchwald-Hartwig coupling and nitrile hydrolysis.The structures of target compounds were characterized by 1H-NMR and ESI-MS.The inhibitory activities of target compounds combined with fluconazole against fluconazole-resistant strain of C.albicans as strain 901,strain 904,strain 632,strain 100,strain 103 and strain 311 were determined by double dilution method.SNX-2112 combined with fluconazole was used as positive control and fluconazole alone was used as negative control.In vitro antifungal activity test showed that most of target compounds presented different degrees of inhibition against various azole-resistant candidiasis.The antifungal activity of compound A11 combined with fluconazole was superior to the positive control.In this paper,the combined use of fluconazole and HSP90 inhibitors against azole-resistant candidiasis was preliminarily explored,which has further research value and provides experience for further research.

HSP90fluconazoleazole-resistant candidiasis

张国祺、刘荣荣、吴旭东、张家琛、高子翾、孙逸祥、赵冬梅

展开 >

沈阳药科大学 基于靶点的药物设计与研究教育部重点实验室,辽宁沈阳 110016

HSP90 氟康唑 抗耐药真菌

2024

中国药物化学杂志
沈阳药科大学,中国药学会

中国药物化学杂志

CSTPCD
影响因子:0.463
ISSN:1005-0108
年,卷(期):2024.34(1)
  • 19